Our staff at the annual HIV conferecne 2018
Interactive board games for drug education created by Gang Saa
Radio program
World AIDS Day event 2018 at Maharaj Hospital

With 27 years of experience in conducting HIV research including HIV vaccine, HIV biomedical prevention

and treatment in various populations to develop academic knowledge on HIV / AIDS,

we have worked in collaboration with leading international research networks and other domestic agencies.

Our diverse research programs are up-to-date with present situation and necessity of knowledge both nationally and globally

We are ready to expand our field of expertise to other challenging infectious diseases and substance use

News and Activities

To find more information, click the image

November 02, 2020
Welcome new collaborative research teams from the C-free project, Raks Thai Foundation, Thai Drug Users' Network and Ozone Foundation at the site initiation meeting at RIHES main building
October 08 and October 22, 2020
The HPTN 083 study team visited the Caremat Health Center and Mplus foundation, community based organizations actively working on HIV prevention for MSMs/TGs and adolescents
Survey Results
Online Alcohol Sales during COVID-19 pandemic
September 28 -29, 2020
Knowledge Sharing Meeting: Exploratory and Qualitative Research in Hard-to-Reach Populations in Songkhla Province
August 26 -28, 2020
Dr. Arunrat Tangmunkongvorakul, as a speaker for a training “How to Conduct Qualitative Research in HIV and Other Health Priorities” at Thai Red Cross AIDS Research Center, Bangkok
August 14, 2020
"Chang for Life" project organized by Gang SAA at the children and youth training center Region 7, Chiang Mai
July 24, 2020
Community Relation Unit newsletter July-September 2020 has been issued. Click the image to read more
Research report
HIV Integrated Behavioral and Biological Surveillance Surveys Among People Who Inject Drugs:Chiang Mai, Thailand-2019
Survey Results
Illegal Liqour in Thai Society
Show More

Research Studies Currently Underway

To learn more, click Study title (to visit webpage) or Study snapshot (in Thai)

Contact Us

Research Institute for Health Sciences, Chiang Mai University
110 Intavaroros Road, Sriphum, Muang
Chiang Mai 50200 THAILAND
Tel. 66 5393 6148

Hepatitis B virus (HBV) vaccine
Nurse Checking Girl
young woman number two sign against comp

The purpose of this study is to evaluate response to and safety of the HBV vaccine HEPLISAV-B in two study populations living with HIV: prior HBV vaccine recipients who are deemed non-responders and individuals who are naïve to HBV vaccination.

Study vaccines: HEPLISAV-B vs. Engerix-B

What the body of children under 12 years of age living with HIV do to these drugs?

Are they safe for this population?

Abacavir/Dolutegravir/Lamivudine Dispersible and

Abacavir/Dolutegravir/Lamivudine Immediate Release Tablets​

A unique regimen containing two

anti-retroviral drugs that might avoid toxicities by minimizing the number of antiretrovirals without sacrificing long-term antiviral efficacy


This study is designed to evaluate the efficacy and safety of DTG/3TC as a FDC, in ART-naive HIV-1-infected adolescents, who weigh at least 25 kilograms (kg). 

©2019 by Research Center for Infectious Diseases and Substance Use. Proudly created with Wix.com